TRANE-TECHNOLOGIES
16.11.2021 09:32:06 CET | Business Wire | Press release
Thermo King® , the transport refrigeration brand of global climate innovator Trane Technologies (NYSE: TT), today premiered its trailer refrigeration system with zero direct carbon emissions at the Solutrans international trade show in Lyon, France.
The Thermo King® AxlePower technology combines a fully electric refrigeration unit, highly efficient battery storage, and the ability to run on low or zero-emissions power sources, such as an axle energy recovery system, shore power or hybrid system. The sustainable battery enables the refrigeration unit to operate autonomously and keep the cargo at optimal temperature, even when the vehicle is not running.
“Safe, sustainable transport of foods, medicines and vaccines is more critical than ever,” said Francesco Incalza, president of Thermo King Europe, Middle East, and Africa. “Temperature-controlled transport is subject to the highest operational safety requirements. Our technology can ensure sensitive goods stay at the required temperature, while reducing energy, emissions, and noise – all important to a sustainable future. We’re proud to continue to deliver breakthrough technology, which supports our customers’ sustainability goals and our Gigaton Challenge to reduce customer carbon emissions by one gigaton by 2030.”
The new solution delivers immediate and long-term sustainability benefits while reducing operating costs. With zero direct emissions and silent operation, it enables inner-city deliveries, including in Ultra-low Emission Zones (ULEZs). Intelligent energy management ensures that there are always enough battery reserves, even on long journeys or in traffic jams. If necessary, the system can also harvest energy from the tractive power of the trailer. All components are monitored in real time by a Thermo King telematics system.
Thermo King will showcase the AxlePower zero-direct emission trailer refrigeration unit powered by BPW’s ePower system at the Solutrans international trade show , Nov. 16-20. Currently in the testing phase, this integrated system recovers energy generated when the vehicle is rolling, sailing or braking and stores it in Thermo King’s efficient battery to power the refrigeration system. This system is tractor-independent and compatible with all Thermo King trailer refrigeration units. The solution has been nominated from more than 100 applications as one of seven finalists for the Solutrans Innovation Award.
Also showcased at the event will be Thermo King’s E200 fully electric unit for small vans and trucks, and the new Advancer Hybrid refrigeration unit, the latest addition to the Advancer A-Series trailer range, which seamlessly switches between the primary electric operating mode to engine power when needed.
“At Trane Technologies, sustainability is at the centre of everything we do as we challenge what’s possible for the industry, and the world,” said Incalza. “For decades, Thermo King has led the industry in electrification of transport refrigeration, and we continue to relentlessly innovate in support of our customers, our communities and our planet.”
Thermo King has committed to invest more than $100 million over the next three years to deliver a fully-electric product in every segment of the cold chain by 2023 in EMEA and 2025 in the Americas.
With its 2030 Sustainability Commitments , Trane Technologies is helping solve for some of the world’s biggest sustainability challenges. These commitments include a pledge to reduce customer greenhouse gas emissions by one gigaton (2% of the world’s annual emissions) and achieve carbon-neutral operations. Its “Opportunity for All” pledge commits to achieving gender parity in leadership, workforce diversity reflective of its communities, and community initiatives that support equitable education and pathways to green and Science, Technology, Engineering and Math (STEM) careers.
About Thermo King
Thermo King – by Trane Technologies (NYSE: TT), a global climate innovator – is a worldwide leader in sustainable transport temperature control solutions. Thermo King has been providing transport temperature control solutions for a variety of applications, including trailers, truck bodies, buses, air, shipboard containers, and railway cars since 1938. For more information, visit www.thermoking.com
or www.europe.thermoking.com
.
About Trane Technologies
Trane Technologies is a global climate innovator. Through our strategic brands Trane® and Thermo King®, and our environmentally responsible portfolio of products and services, we bring efficient and sustainable climate solutions to buildings, homes, and transportation. Learn more at tranetechologies.com
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211116005093/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom